Health and safety advice for the Catapult comes from S.H.E Advises
- Cell and Gene Therapy Catapult
- London
- Below threshold - without competition
- 13 April 2026 to 13 April 2027
Cell and Gene Therapy Catapult awarded S.H.E Advises an environmental, health and safety consultancy contract directly, without a competition. The Catapult gave the reason as an urgent, business-critical need for health and safety help straight away.
The adviser's job is to keep environmental and safety standards in place and the Catapult's regulatory duties met.
The award was £81,975, and the notice puts the contract at £98,370 including VAT. It runs from April 2026 to April 2027.
Contract ends April 2027
- What
- Health and safety consultancy
- Supplier
- S.H.E Advises
- Value
- £81,975
- How it was bought
- Below threshold - without competition
- Dates and next
- Apr 2026 to Apr 2027